Halozyme Therapeutics shares owned by Oak Ridge Investments
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Oak Ridge Investments
from 13F filings
Historical chart of Oak Ridge Investments investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Oak Ridge Investments consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Oak Ridge Investments
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $2.9M | 72k | 40.68 |
| 2023-12-31 | $2.8M | 76k | 36.96 |
| 2023-09-30 | $3.1M | 82k | 38.20 |
| 2023-06-30 | $3.1M | 85k | 36.07 |
| 2023-03-31 | $3.3M | 87k | 38.19 |
| 2022-12-31 | $5.3M | 93k | 56.90 |
| 2022-09-30 | $3.8M | 95k | 39.54 |
| 2022-06-30 | $4.2M | 96k | 43.99 |
| 2022-03-31 | $4.0M | 101k | 39.88 |
| 2021-12-31 | $6.4M | 159k | 40.21 |
| 2021-09-30 | $6.6M | 162k | 40.69 |
| 2021-06-30 | $7.6M | 167k | 45.41 |
| 2021-03-31 | $7.4M | 179k | 41.69 |
| 2020-12-31 | $7.8M | 183k | 42.71 |
| 2020-09-30 | $5.9M | 225k | 26.28 |